Clinical Trial Update: Transfer of Subjects From Subutex/Suboxone to RBP-6300 [Phase 2]

View source ↗

Summary

The document reports a Phase 2 study update. It describes the transfer of subjects from buprenorphine formulations Subutex/Suboxone to the long-acting RBP-6300 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• RBP-6300
• SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)
• Subutex (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Related Disorder | Phase 2 | Status: COMPLETED